1. Veterinary Diagnostics: Disease
Threats to Animals Will Boost
Need for New Tests
There are many diseases that can affect cattle, pigs and other livestock and
endanger the food supply. Swine fever, neosporosis, foot-and-mouth
disease and other diseases are among the threats to animals that humans
eat. Test makers have answered the call to develop products that can help
food manufacuters and government agencies protect livestock and ensure a
safe food supply at the beginning of the chain. For this reason, the
Veterinary Diagnostics market can expect healthy revenue growth
according to a recent Kalorama Information report on the topic. It’s a less
regulated area than human clinical IVD, and companies that make diagnostic products have been attracted by the
faster approval times and in some cases higher profit margins. While of the two sub markets within this market pet
diagnostics is stronger in terms of growth than food animal diagnostics. Kalorama still thinks food animal
diagnostics will drive growth in the market.
It’s hard to predict animal disease, but a lot is going on in this market. Emerging nations are beginning disease
control and eradication programs and this will boost global markets for food animal diagnostics. There’s another
factor – new products to test animals. The penetration of easy-to-use molecular diagnostic test kits for veterinary
infectious diseases also represents another factor improving the value of the global food animal diagnostics market.
U.S. veterinary diagnostics have predominated in the companion animal or pet segment. Since 2012, new market
players for animal tests in the United States – Biogal/Galed Laboratories, Princeton BioMeditech, and InBios –
launched tests for canine distemper, canine heartworm, and West Nile virus. to the significantly wider portfolio
of livestock disease tests.
Europe has seen more food animal testing, where several disease eradication programs boosted livestock testing in
the past decade. Kalorama found 14 livestock infectious disease tests in the US delisted (as part of portfolio
management or company withdrawal from the market) and 9 introduced (in most cases with competitive tests
already on the market). So that’s more tests off the market than on. Three of the tests removed were from vendors
still offering a “me too” test – a test for the same target disease. The near equal rates of product addition and attrition
indicate a largely flat market for U.S. livestock infectious disease diagnostics. Market growth is predicated upon
disease outbreaks and management; the United States has seen no recent, market-significant outbreaks and active
disease eradication programs have focused overwhelmingly on industry practices and vaccination.
NEW FROM Kalorama Information
Veterinary Diagnostics Markets
Complete Estimates and Forecasts of the
Animal Testing Market
